<DOC>
	<DOCNO>NCT02079675</DOCNO>
	<brief_summary>The purpose study determine efficacy safety different dos SKI3246 compare placebo treatment patient irritable bowel syndrome non-constipation .</brief_summary>
	<brief_title>Study Assess Efficacy Safety SKI3246 Subjects With Non-Constipation Irritable Bowel Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>Have diagnose nonconstipation ROME III . Patients voluntarily sign write informed consent may participate study . Pregnant lactate female . Patients history inflammatory bowel disease . Severe neurological psychological disease History allergic reaction medication use study Use investigational drug within 30 day prior study . Patients investigator consider ineligible study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>